Evolus (EOLS) Capital Expenditures (2018 - 2026)

Evolus (EOLS) reported Capital Expenditures of $415000.0 for Q1 2026, up 30.09% on a YoY basis from $319000.0 in Q1 2025, and down 71.94% quarter-over-quarter from $1.5 million in Q4 2025.

Evolus (EOLS) Capital Expenditures (2018 - 2026) Analysis & Trends

Evolus has reported Capital Expenditures for 9 years, with the latest figure at $415000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Capital Expenditures rose 30.09% year-over-year to $415000.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 1022.86% YoY), and the FY2025 full-year result was $3.4 million, up 1265.48% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $415000.0, down from $1.5 million in the prior quarter.
  • The five-year high for Capital Expenditures was $1.5 million in Q4 2025, with the low at -$782000.0 in Q4 2024.
  • Historically, Capital Expenditures has averaged $347176.5 across 5 years, with a median of $313000.0 in 2024.
  • Annual changes were most pronounced in 2022 — Capital Expenditures soared 7600.0% — and 2024, when it plunged 474.16%.
  • Evolus' Capital Expenditures stood at $569000.0 in 2022, then plunged by 63.27% to $209000.0 in 2023, then sank by 474.16% to -$782000.0 in 2024, then surged by 289.13% to $1.5 million in 2025, then tumbled by 71.94% to $415000.0 in 2026.
  • The last three Capital Expenditures figures came in at $415000.0 (Q1 2026), $1.5 million (Q4 2025), and $955000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 168.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 110.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 100.80 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 9.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 51.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.09 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 8.83 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.04 Mn
10 Evolus 437.40 Mn 387.61 Mn 48.90 Mn 415,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 415,000.00
Mar 31, 2026 415,000.00
Dec 31, 2025 1.48 Mn
Dec 31, 2025 1.48 Mn
Sep 30, 2025 955,000.00
Sep 30, 2025 955,000.00
Jun 30, 2025 688,000.00
Jun 30, 2025 688,000.00
Mar 31, 2025 319,000.00
Mar 31, 2025 319,000.00
Dec 31, 2024 -782,000.00
Dec 31, 2024 -782,000.00
Sep 30, 2024 313,000.00
Sep 30, 2024 313,000.00
Jun 30, 2024 465,000.00
Jun 30, 2024 465,000.00
Mar 31, 2024 256,000.00
Mar 31, 2024 256,000.00
Dec 31, 2023 209,000.00
Dec 31, 2023 209,000.00